LAKE FOREST, Ill.–(BUSINESS WIRE)–Jaguar Gene Therapy today announced results of two preclinical studies of JAG101 in two different animal models of Type 1 galactosemia.
News Ticker
- [ October 6, 2026 ] City of Hope Names New Presidents of Cancer Centers in Arizona and Atlanta Los Angeles Biotech News
- [ October 6, 2026 ] MidFirst Bank Donates $35,000 to The Heart Foundation to Support Heart Disease Research and Awareness Los Angeles Biotech News
- [ October 6, 2026 ] New World Medical Receives MDR Certification for Ahmed® Glaucoma Valve, Ahmed ClearPath®, and KDB GLIDE® Los Angeles Biotech News
- [ October 6, 2026 ] Infleqtion, Honeywell Aerospace and UC Santa Barbara Collaborate to Accelerate Miniaturization and Manufacturability of Quantum Hardware Los Angeles Biotech News
- [ October 6, 2026 ] Prostate Cancer Foundation Honors Mary-Ellen Taplin, MD, with the 2026 PCF Women in Science Lifetime Achievement Award Los Angeles Biotech News
Copyright © 2026 Biotech Networks, LLC
